“…Non-natural oligonucleotides have attracted a great deal of interest among researchers working with antisense and anti-gene technologies (Hiratou et al, 1999;Paillart et al, 2004;Sanghvi and Cook, 1994), triple helix therapies (De Mesmaeker et al, 1995;Uhlmann and Peyman, 1990), and nucleic acid nanotechnology (Gold et al, 1995). Among the various modifications of DNA strands, base or sugar changes (Eppacher et al, 2000;Lee and Kool, 2009;Perez-Rentero et al, 2009;Roig and Asseline, 2009), those of internucleosidic linkers are very promising, since they render the backbone virtually insensitive to acid/alkaline or enzymatic hydrolysis.…”